Table 1.
Characteristics | N (%)* |
---|---|
Age, average (range) | 54.9 (22 – 79) |
Sex | |
Female | 126 (58) |
Male | 90 (42) |
Ethnicity | |
White | 143 (66) |
Black | 43 (20) |
Hispanic | 28 (13) |
Others | 2 (1) |
Education | |
High school or lower | 115 (53) |
College | 72 (33) |
Advanced | 29 (14) |
Cancer | |
Breast | 27 (13) |
Gastrointestinal | 71 (33) |
Genitourinary | 19 (9) |
Gynecological | 23 (11) |
Head and neck | 10 (5) |
Hematological | 12 (6) |
Others | 18 (8) |
Respiratory | 36 (17) |
Overall survival in days, median (95% confidence interval) | 109 (71–133) |
Clinician prediction of survival (Raw-CPS) in days, median (interquartile range) | 90 (60–155) |
Palliative prognostic score (PaP-total score) | |
0–5.5 points | 152 (70) |
5.6–11 points | 16 (8) |
11.1–17.5 points | 48 (22) |
Clinician prediction of survival transformed into PaP score categories (PaP-CPS) | |
>12 weeks (0 point) | 128 (59) |
11–12 weeks (2 points) | 3 (1) |
7–10 weeks (2.5 points) | 48 (22) |
5–6 weeks (4.5 points) | 11 (5) |
3–4 weeks (6 points) | 23 (11) |
<=2 weeks (8.5 points) | 3 (1) |
Dyspnea in PaP score categories | |
Absent (0 point) | 125 (58) |
Present (1 point) | 91 (42) |
Anorexia in PaP score categories | |
Absent (0 point) | 187 (87) |
Present (1.5 points) | 29 (13) |
Karnofsky performance status in PaP score categories | |
≥50% (0 point) | 182 (84) |
≤40% (2.5 points) | 34 (16) |
Leukocytosis in PaP score categories | |
≤8500 cell/mm3 (0 point) | 130 (60) |
8501–11000 cell/mm3 (0.5 point) | 42 (20) |
>11000 cell/mm3 (1.5 points) | 44 (20) |
Lymphocytopenia in PaP score categories | |
≥20% (0 point) | 42 (20) |
12%-19.9% (1 point) | 46 (21) |
0–11.9% (2.5 points) | 128 (59) |
Abbreviations: SD, standard deviation
unless otherwise specified